Literature DB >> 21796326

[Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].

A Gessain1.   

Abstract

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus discovered in 1980. It is estimated that around 10-20 million people are infected with HTLV-1 worldwide. However, HTLV-1 is not a ubiquitous virus. Indeed, HTLV-1 is present throughout the world with clusters of high endemicity including mainly southern Japan, the Caribbean region, parts of South America and intertropical Africa, with foci in the Middle East and Australia. The origin of this puzzling geographical repartition is probably linked to a founder effect in certain human groups. In the high endemic areas, 0.5 to 50% of the people have antibodies against HTLV-1 antigens. HTLV-1 seroprevalence increases with age, especially in women. HTLV-1 has 3 modes of transmission: mother to child, mainly through prolonged breastfeeding (> 6 months); sexual, mainly but not exclusively occurring from male to female; and by blood products contaminated by infected lymphocytes. HTLV-1 is mainly the etiological agent of two very severe diseases: a malignant T CD4+ cell lymphoproliferation of very poor prognosis, named adult T-cell leukemia/lymphoma (ATLL), and a chronic neuro-myelopathy named tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). HTLV-1 is also associated with rare anterior uveitis, infective dermatitis and myositis in some high HTLV-1 endemic areas. The repartition of the different molecular subtypes or genotypes is mainly linked to the geographical origin of the infected persons but not to the associated pathology. HTLV-1 possesses a remarkable genetic stability probably linked to viral amplification via clonal expansion of infected cells rather than by reverse transcription. This stability can be used as a molecular tool to gain better insights into the origin, evolution and modes of dissemination of HTLV-1 and infected populations. HTLV-1 originated in humans through interspecies transmission from STLV-1, a very closely related retrovirus, highly endemic in several populations of apes and Old World monkeys.

Entities:  

Mesh:

Year:  2011        PMID: 21796326     DOI: 10.1007/s13149-011-0174-4

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  16 in total

1.  High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo.

Authors:  Ahuka-Mundeke Steve; Ayouba Ahidjo; Mbala-Kingebeni Placide; Foncelle Caroline; Mubonga Mukulumanya; Ndimbo-Kumugo Simon-Pierre; Lunguya-Metila Octavie; Mbenzo-Abokome Valentin; Muyembe-Tamfum Jean-Jacques; Delaporte Eric; Peeters Martine
Journal:  Ecohealth       Date:  2017-01-03       Impact factor: 3.184

Review 2.  Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.

Authors:  Rita Hleihel; Abdou Akkouche; Hala Skayneh; Olivier Hermine; Ali Bazarbachi; Hiba El Hajj
Journal:  Curr Oncol Rep       Date:  2021-11-04       Impact factor: 5.075

Review 3.  Origin and diversity of human retroviruses.

Authors:  Martine Peeters; Mirela D'Arc; Eric Delaporte
Journal:  AIDS Rev       Date:  2014 Jan-Mar       Impact factor: 2.500

4.  Simian T-lymphotropic Virus-associated lymphoma in 2 naturally infected baboons: T-cell clonal expansion and immune response during tumor development.

Authors:  Jean M d'Offay; Richard Eberle; Roman F Wolf; Stanley D Kosanke; Kelly R Doocy; Sahlu Ayalew; Keith G Mansfeild; Gary L White
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

5.  Adult T-cell lymphoma/leukaemia with haematemesis as a prodromal manifestation.

Authors:  Fariba Binesh; Mohamad Reza Mirjalili; Hasanali Vahedian; Hamidreza Bashiri
Journal:  BMJ Case Rep       Date:  2012-11-28

6.  New STLV-3 strains and a divergent SIVmus strain identified in non-human primate bushmeat in Gabon.

Authors:  Florian Liégeois; Vanina Boué; Fatima Mouacha; Christelle Butel; Bertrand Mve Ondo; Xavier Pourrut; Eric Leroy; Martine Peeters; François Rouet
Journal:  Retrovirology       Date:  2012-03-30       Impact factor: 4.602

7.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

8.  [Diffuse interstitial lung disease revealing adult T-Cell leukemia/lymphoma (HTLV-1)].

Authors:  Nouama Bouanani; Mouna Lamchahab
Journal:  Pan Afr Med J       Date:  2016-11-14

9.  Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellín-Colombia, 2014-2018.

Authors:  Jaiberth Antonio Cardona-Arias; Carolina Vélez-Quintero; Olga Victoria Calle-González; Jennifer Florez-Duque; Juan Carlos Zapata
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

Review 10.  "HTLV-I Infection" Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences.

Authors:  Ali Shoeibi; Mohammdmahdi Etemadi; Amir Moghaddam Ahmadi; Mona Amini; Reza Boostani
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.